↓ Skip to main content

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
127 Dimensions

Readers on

mendeley
89 Mendeley
Title
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Published in
Breast Cancer Research and Treatment, December 2012
DOI 10.1007/s10549-012-2355-3
Pubmed ID
Authors

Holm Eggemann, Atanas Ignatov, Bobbie J. Smith, Udo Altmann, Gunter von Minckwitz, Freidrich W. Röhl, Mark Jahn, Serban-Dan Costa

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United Kingdom 1 1%
Unknown 87 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 12%
Student > Doctoral Student 11 12%
Student > Master 10 11%
Other 7 8%
Student > Postgraduate 6 7%
Other 19 21%
Unknown 25 28%
Readers by discipline Count As %
Medicine and Dentistry 40 45%
Biochemistry, Genetics and Molecular Biology 4 4%
Nursing and Health Professions 3 3%
Agricultural and Biological Sciences 3 3%
Chemistry 2 2%
Other 7 8%
Unknown 30 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2021.
All research outputs
#2,513,175
of 26,017,215 outputs
Outputs from Breast Cancer Research and Treatment
#338
of 5,117 outputs
Outputs of similar age
#22,921
of 290,661 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#7
of 67 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,117 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,661 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.